Catalyst Wire Dossier Catalyst Wire Dossier

Sandostatine

octreotide · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sandostatine, covering 2015-08-19 to 2015-08-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002) [Phase 1]

See pricing